Post-approval studies (Phase 4)Study completedNCT01256658
What this trial is testing
A Community Setting Study of Malaria After Systematic Treatment of Symptomatic Carriers of P. Falciparum With COA566 (Coartem®)
Who this might be right for
Malaria
Novartis 14,075